Back to News
Market Impact: 0.2
Pulse Biosciences Consensus Price Target Increased by 15.43% to $63.58
Source: Nasdaq
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
Fintel-compiled aggregate analyst price target for Pulse Biosciences rose 15.43% to $63.58 per share from $55.08, the prior estimate dated September 29, 2026. The article provides no current share price or additional context for the target revision.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
PLSE0.30
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Oncologists Cheer Melanoma Data
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Investing.com’s stocks of the week